Skip to main content

Table 3 The relationships between the myxoid stroma and clinicopathological characteristics analyzed using χ2 and Fisher’s exact tests

From: Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer

  Myxoid    Myxoid  
Absent (%) Present (%) p value   Absent (%) Present (%) p value
Gender)     Lymphatic invasion    
 Female 62 (45) 13 (41) 0.7  Absent 87 (64) 17 (53) 0.36
 Male 75 (55) 19 (59)  Present 50 (36) 15 (47)
Age     Vessel invasion    
  < 70 53 (39) 16 (50) 0.32  Absent 61 (45) 10 (31) 0.23
  ≥ 70 84 (61) 16 (50)  Present 76 (55) 22 (69)
Serum CEA value     Tumor budding    
  < 5 85 (62) 21 (66) 0.84  Grade 1 100 (73) 6 (19) < 0.001
  ≥ 5 52 (38) 11 (34)  Grade 2, 3 37 (27) 26 (81)
Serum CA19–9 value     Surgical margin    
  < 37 116 (85) 27 (84) 0.26  Negative 133 (97) 31 (97) 1*
  ≥ 37 21 (15) 5 (16)  Positive 4 (3) 1 (3)
Tumor location     Examined lymph node   
 Right 72 (53) 16 (50) 0.85   < 12 42 (31) 12 (38) 0.53
 Left 65 (47) 16 (50)   ≥ 12 95 (69) 20 (62)
Tumor size (cm)     Obstruction/perforation   
  < 5 63 (46) 18 (56) 0.33  Absent 128 (93) 29 (91) 0.7*
  ≥ 5 74 (54) 14 (44)  Present 9 (7) 3 (9)
Differentiation     Glucose tolerance    
 Well, moderately, pap 121 (88) 29 (91) 1*  Normal 95 (69) 25 (78) 0.39
 Por, Muc, Sig 16 (12) 3 (9)  Abnormality 42 (31) 7 (22)
Tumor depth     Tumor relapse    
 pT3 118 (86) 26 (81) 0.58  Absent 129 (94) 17 (53) < 0.001
 pT4 19 (14) 6 (19)  Present 8 (6) 15 (47)
  1. *Fisher’s exact tests